Generics, OTCs
Total Trials
24
As Lead Sponsor
23
As Collaborator
1
Total Enrollment
26,361
NCT00404989
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
Phase: N/A
Role: Collaborator
Start: Jan 31, 1989
Completion: Jan 31, 2099
NCT01421563
Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2011
Completion: Feb 28, 2011
NCT01421576
Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions
Start: Jul 31, 2011
Completion: Jul 31, 2011
NCT01429688
Pharmacokinetic / Pharmacodynamic (PK/PD) Study of Multiple Doses of DP-R202 in Healthy Volunteers
Completion: Aug 31, 2011
NCT01429675
Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers
Start: Aug 31, 2011
Completion: Mar 31, 2012
NCT01581320
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Phase: Phase 3
Start: Dec 31, 2011
Completion: Sep 30, 2012
NCT01577849
Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers
Start: Mar 31, 2012
Completion: Jun 30, 2012
NCT02393612
Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease
Start: Oct 31, 2012
Completion: Apr 30, 2014
NCT02718846
Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets
Phase: Phase 4
Start: Feb 28, 2013
Completion: May 31, 2015
NCT02079506
Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin
Start: Feb 28, 2014
Completion: Feb 28, 2014
NCT02445352
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
Start: Jul 31, 2014
Completion: Mar 31, 2015
NCT02730689
A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone
Start: Dec 31, 2014
Completion: Jan 31, 2015
NCT02707224
Clinical Trial to Compare the Pharmacokinetics of DP-R208
Start: Jan 31, 2015
Completion: Jun 30, 2015
NCT02770261
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy
Start: Dec 31, 2015
Completion: Oct 31, 2016
NCT02654093
A Drug-drug Interaction Study of DP-R213
Start: Jan 31, 2016
Completion: Mar 31, 2016
NCT02709187
DP-R208 Pharmacokinetic Study
Start: Mar 31, 2016
Completion: May 31, 2016
NCT02762643
DP-R213 Pharmacokinetics Study
Start: May 31, 2016
Completion: Aug 31, 2016
NCT02789475
DP-R212 Pharmacokinetic Study
Completion: Jul 31, 2016
NCT02814500
DP-R212 Pharmacokinetic Study Phase I
Start: Jul 31, 2016
Completion: Sep 30, 2016
NCT03005340
A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male Volunteers
Start: Dec 31, 2016
Completion: Jun 30, 2017
NCT03010267
DP-R213 Phase 1 Pharmacokinetics Study
Start: Jan 3, 2017
Completion: Mar 29, 2017
NCT02955368
Clinical Trial to Evaluate the Efficacy and Safety of DP-R212
Start: Feb 28, 2017
Completion: Aug 31, 2017
NCT03321318
AK-R215 Pharmacokinetic Study Phase I
Start: Jul 13, 2017
Completion: Jan 12, 2018
NCT05378503
Phase IV Study of Qsymia in Obese Patients
Start: Sep 17, 2021
Completion: Oct 30, 2023
Loading map...